Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System)
- DOI
- 10.3390/curroncol33090530
- Published
- 2026-09-02
- Container
- Current Oncology
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/curroncol33090530,
title = {Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System)},
author = {Zaid Ahmed and Rashid Sayyid and Omid Yazdanpanah and Ravand Samaeekia and Arash Rezazadeh Kalebasty and David I. Lee and Mohammed Shahait},
year = {2026},
journal = {Current Oncology},
doi = {10.3390/curroncol33090530},
url = {https://doi.org/10.3390/curroncol33090530}
}RIS
TY - JOUR TI - Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System) AU - Zaid Ahmed AU - Rashid Sayyid AU - Omid Yazdanpanah AU - Ravand Samaeekia AU - Arash Rezazadeh Kalebasty AU - David I. Lee AU - Mohammed Shahait PY - 2026 JO - Current Oncology DO - 10.3390/curroncol33090530 UR - https://doi.org/10.3390/curroncol33090530 ER -
APA
Ahmed, Z., Sayyid, R., Yazdanpanah, O., Samaeekia, R., Kalebasty, A. R., Lee, D. I., & Shahait, M. (2026). Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System). Current Oncology. https://doi.org/10.3390/curroncol33090530
Source records
- crossref · retrieved 2026-09-25T07:28:16.541Z